Amyloidosis, other/unspecified

E4_AMYLNAS

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 E85[8-9]
Hospital discharge: ICD-9 2773
Hospital discharge: ICD-8 27699
Cause of death: ICD-10 E85[8-9]
Cause of death: ICD-9 2773
Cause of death: ICD-8 27699

592

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

305

diagram downward connector

Check minimum number of events None

305

diagram downward connector

Include endpoints None

305

diagram downward connector
E4_AMYLNAS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 299 157 142
Unadjusted prevalence (%) 0.10 0.09 0.11
Mean age at first event (years) 61.39 59.11 63.92

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_AMYLNAS – Amyloidosis, other/unspecified
GWS hits: 6

Survival analyses between endpoints

Plot

before Amyloidosis, other/unspecified
after Amyloidosis, other/unspecified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Amyloidosis, other/unspecified